Asia-Pacific Home Healthcare Market Outlook, 2028

The Asia Pacific Home Healthcare market is anticipated to grow at more than 9% CAGR by 2023–28

Featured Companies

  • 1. Beckton Dickinson
  • 2. Sanofi S.A.
  • 3. Abbott Laboratories
  • 4. Glanbia plc
  • 5. Medtronic plc
  • 6. B. Braun Melsungen AG
  • More...

The Asia Pacific region has been experiencing a significant increase in the elderly population. As people age, there is a higher demand for healthcare services, including home healthcare, to manage chronic conditions and provide personalized care. The rising incidence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory disorders, has contributed to the demand for home healthcare services. Patients prefer to receive treatment and monitoring in the comfort of their homes. Home healthcare can be a cost-effective solution compared to hospital-based care. As healthcare costs continue to rise, both patients and healthcare providers may seek alternatives that provide quality care at a lower cost, driving the adoption of home healthcare services. In many parts of the Asia Pacific region, especially in rural and remote areas, access to healthcare facilities is limited. Home healthcare services become crucial in addressing this gap, allowing patients in underserved areas to receive necessary medical attention without the need for long-distance travel. The availability of insurance coverage and favorable reimbursement policies for home healthcare services can significantly influence the adoption of these services. Governments and insurance providers working to include home healthcare in coverage plans can stimulate market growth. Cultural factors can impact healthcare preferences. In some Asian cultures, there is a strong emphasis on family and home care. As a result, home healthcare services align well with cultural values and preferences. Advances in the development of portable and user-friendly medical devices and equipment support the provision of home healthcare. The availability of reliable and easy-to-use devices enhances the feasibility and acceptance of home-based care.

According to the research report, "Asia-Pacific Home Healthcare Market Outlook, 2028," published by Bonafide Research, the Asia Pacific Home Healthcare market is anticipated to grow at more than 9% CAGR by 2023–28. The adoption of telehealth services and remote monitoring solutions has been a significant trend in the Asia Pacific home healthcare market. Telehealth enables healthcare professionals to monitor patients remotely, offer virtual consultations, and provide timely interventions, improving overall patient care and reducing the need for physical visits. AI and data analytics are increasingly being integrated into home healthcare services. These technologies help in predicting health outcomes, personalizing treatment plans, and optimizing care delivery. AI-driven applications may assist in medication management, health monitoring, and early detection of potential health issues. The use of wearable devices for health monitoring has become prevalent. Wearables, such as smartwatches and fitness trackers, allow continuous monitoring of vital signs and can provide valuable data for healthcare professionals. This trend supports proactive healthcare management and preventive measures. The proliferation of smartphones and mobile applications has led to the development of mHealth solutions. These applications offer features such as medication reminders, health tracking, and virtual consultations, making healthcare more accessible and convenient for patients in their homes. The emergence of digital health platforms that connect patients, caregivers, and healthcare providers is contributing to the efficiency and coordination of home healthcare services. These platforms facilitate communication, appointment scheduling, and the exchange of health information in a secure and integrated manner.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


In China, a rapidly aging population and the increasing prevalence of chronic diseases have driven the demand for home healthcare services. The Chinese government's recognition of the importance of home-based care is reflected in supportive policies and initiatives aimed at integrating home healthcare into the broader healthcare system. Telehealth and remote monitoring technologies have gained traction, facilitating virtual consultations and continuous health monitoring. Additionally, the Chinese home healthcare market has seen advancements in artificial intelligence (AI) applications, contributing to personalized treatment plans and improved patient outcomes. In India, a similar trend is evident as the country grapples with the challenges posed by a large and diverse population. The rising incidence of chronic diseases, coupled with an aging demographic, has propelled the need for accessible and patient-centric healthcare solutions. Home healthcare services in India have expanded beyond basic medical care to encompass a wide range of specialized services, including physiotherapy, post-surgical care, and geriatric support. Mobile health applications and wearable devices are increasingly being embraced to enhance patient engagement and enable remote monitoring. Furthermore, the Indian government has been actively promoting home healthcare through policy measures and incentives, recognizing its potential to alleviate the burden on traditional healthcare infrastructure.

In terms of Product & Services the market is categorized into Therapeutic, Testing, Screening, and Monitoring (TSM), Mobility and Services. The Asia Pacific region is experiencing a significant demographic shift with a rapidly aging population. As people age, there is an increased likelihood of mobility issues, such as difficulty in walking or moving around. The growing aging population creates a higher demand for mobility assistance devices and services to support independent living at home. Patients recovering from surgeries or injuries often require mobility assistance during the rehabilitation phase. Home healthcare services that include mobility aids, such as crutches, walkers, and wheelchairs, play a crucial role in facilitating the recovery process at home. The convenience of receiving post-surgery care in a familiar environment contributes to the growth of the mobility segment. Alongside mobility aids, there is an increasing focus on home accessibility modifications. Home healthcare services may involve assessments and recommendations for home modifications, such as ramps, handrails, and bathroom modifications, to enhance accessibility and mobility within the home environment. Many individuals prefer to receive care in the comfort of their homes, especially when dealing with mobility issues. Home healthcare services that address mobility needs allow individuals to maintain a higher level of independence and autonomy, supporting their desire to age in place. Caregivers, whether family members or professional caregivers, play a crucial role in assisting individuals with mobility challenges. Home healthcare services often include caregiver training and support to ensure that caregivers can provide effective assistance while maintaining the well-being of both the caregiver and the individual receiving care.

Based on Indication the market is segmented into Cardiovascular Disorders & Hypertension, Cancer, Diabetes, Respiratory Diseases, Movement Disorders, Pregnancy, Hearing Disorders, Wound Care and Other Indications. Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality globally, including in the Asia Pacific region. The prevalence of conditions such as coronary artery disease, heart failure, and hypertensive disorders is significant, contributing to a high demand for specialized home healthcare services to manage and monitor these cardiovascular disorders. Hypertension, or high blood pressure, is a common and major risk factor for cardiovascular diseases. The Asia Pacific region has witnessed a rising incidence of hypertension, often associated with lifestyle changes, dietary habits, and an aging population. Given the importance of managing hypertension to prevent cardiovascular complications, there is a heightened focus on this segment. Home healthcare services for cardiovascular disorders often include preventive care strategies and lifestyle management. This may involve educating patients on dietary changes, exercise routines, stress management, and smoking cessation. By addressing modifiable risk factors, home healthcare contributes to preventing the progression of cardiovascular diseases. Stroke and other cerebrovascular diseases are often associated with hypertension and cardiovascular disorders. The Asia Pacific region has seen a notable prevalence of stroke cases, and home healthcare services are crucial for the management, rehabilitation, and prevention of complications related to cerebrovascular events.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Companies Covered in this report:

Novo Nordisk A/S, Sanofi S.A., Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, Baxter International Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Abbott Laboratories , Koninklijke Philips N.V.

Considered in this report

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval


• Geography: Asia Pacific
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Asia Pacific Home Healthcare market Outlook with its value and forecast along with its segments
• Country-wise Home Healthcare market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• China
• Japan
• India
• Australia
• South Korea

By Product & Services

• Therapeutic
• Testing, Screening, and Monitoring (TSM)
• Mobility
• Services

By Indication

• Cardiovascular Disorders & Hypertension
• Cancer
• Diabetes
• Respiratory Diseases
• Movement Disorders
• Pregnancy
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Home Healthcare industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.







Companies Mentioned

  • Beckton Dickinson
  • Sanofi S.A.
  • Abbott Laboratories
  • Glanbia plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Huntsman International LLC
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG,
  • Fresenius Medical Care AG & Co. KGaA

Table of Contents

  • Table of Contents
  • 1. Executive Summary
  • 2. Research Methodology
  • 2.1. Secondary Research
  • 2.2. Primary Data Collection
  • 2.3. Market Formation & Validation
  • 2.4. Report Writing, Quality Check & Delivery
  • 3. Market Structure
  • 3.1. Market Considerate
  • 3.2. Assumptions
  • 3.3. Limitations
  • 3.4. Abbreviations
  • 3.5. Sources
  • 3.6. Definitions
  • 4. Economic /Demographic Snapshot
  • 5. Global Home Healthcare Market Outlook
  • 5.1. Market Size By Value
  • 5.2. Market Share By Region
  • 5.3. Market Size and Forecast, By Product and Services
  • 5.4. Market Size and Forecast, By Indication
  • 6. Asia-Pacific Home Healthcare Market Outlook
  • 6.1. Market Size By Value
  • 6.2. Market Share By Country
  • 6.3. Market Size and Forecast, By Product and Services
  • 6.4. Market Size and Forecast, By Indication
  • 7. Market Dynamics
  • 7.1. Market Drivers & Opportunities
  • 7.2. Market Restraints & Challenges
  • 7.3. Market Trends
  • 7.4. Covid-19 Effect
  • 7.5. Supply chain Analysis
  • 7.6. Policy & Regulatory Framework
  • 7.7. Industry Experts Views
  • 7.8. China Home Healthcare Market Outlook
  • 7.8.1. Market Size By Value
  • 7.8.2. Market Size and Forecast By Product and Services
  • 7.8.3. Market Size and Forecast By Indication
  • 7.9. Japan Home Healthcare Market Outlook
  • 7.9.1. Market Size By Value
  • 7.9.2. Market Size and Forecast By Product and Services
  • 7.9.3. Market Size and Forecast By Indication
  • 7.10. India Home Healthcare Market Outlook
  • 7.10.1. Market Size By Value
  • 7.10.2. Market Size and Forecast By Product and Services
  • 7.10.3. Market Size and Forecast By Indication
  • 7.11. Australia Home Healthcare Market Outlook
  • 7.11.1. Market Size By Value
  • 7.11.2. Market Size and Forecast By Product and Services
  • 7.11.3. Market Size and Forecast By Indication
  • 7.12. South Korea Home Healthcare Market Outlook
  • 7.12.1. Market Size By Value
  • 7.12.2. Market Size and Forecast By Product and Services
  • 7.12.3. Market Size and Forecast By Indication
  • 8. Competitive Landscape
  • 8.1. Competitive Dashboard
  • 8.2. Business Strategies Adopted by Key Players
  • 8.3. Key Players Market Positioning Matrix
  • 8.4. Porter's Five Forces
  • 8.5. Company Profile
  • 8.5.1. Novo Nordisk A/S
  • 8.5.1.1. Company Snapshot
  • 8.5.1.2. Company Overview
  • 8.5.1.3. Financial Highlights
  • 8.5.1.4. Geographic Insights
  • 8.5.1.5. Business Segment & Performance
  • 8.5.1.6. Product Portfolio
  • 8.5.1.7. Key Executives
  • 8.5.1.8. Strategic Moves & Developments
  • 8.5.2. Sanofi S.A.
  • 8.5.3. Medtronic plc
  • 8.5.4. Terumo Corporation
  • 8.5.5. Becton, Dickinson and Company
  • 8.5.6. F. Hoffmann-La Roche AG
  • 8.5.7. B. Braun Melsungen AG
  • 8.5.8. Baxter International Inc.
  • 8.5.9. Nipro Corporation
  • 8.5.10. Fresenius Medical Care AG & Co. KGaA
  • 8.5.11. Abbott Laboratories
  • 8.5.12. Koninklijke Philips N.V.
  • 9. Strategic Recommendations
  • 10. Annexure
  • 10.1. FAQ`s
  • 10.2. Notes
  • 10.3. Related Reports
  • 11. Disclaimer

List of Table
Table 1 : Global Home Healthcare Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 6 : Global Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 7 : Asia-Pacific Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 8 : Asia-Pacific Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 9 : Influencing Factors for Home Healthcare Market, 2022
Table 10 : China Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 11 : China Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 12 : Japan Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 13 : Japan Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 14 : India Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 15 : India Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 16 : Australia Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 17 : Australia Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 18 : South Korea Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 19 : South Korea Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

List of Figures
Figure 1: Global Home Healthcare Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Home Healthcare Market Share By Region (2022)
Figure 6: Asia-Pacific Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: Asia-Pacific Home Healthcare Market Share By Country (2022)
Figure 8: China Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Japan Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: India Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Australia Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: South Korea Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: Competitive Dashboard of top 5 players, 2022
Figure 14: Porter's Five Forces of Global Home Healthcare Market
?

Market Research FAQs

Home healthcare services in the Asia Pacific region include skilled nursing care, rehabilitation services, home-based chronic disease management, and personal care assistance. The range of services may vary across different countries.

Similar to trends in other regions, technology is playing a crucial role in the Asia Pacific Home Healthcare Market. Telehealth, remote patient monitoring, and digital health solutions are being increasingly adopted to improve accessibility and quality of care.

Factors such as a rapidly aging population, a growing burden of chronic diseases, increasing healthcare awareness, and the desire for cost-effective and patient-centric care are driving the growth of the home healthcare market in the Asia Pacific region.

Regulatory challenges may vary across countries in the Asia Pacific region. Differences in healthcare regulations, reimbursement policies, and workforce training standards can pose challenges to the expansion of home healthcare services.

Emerging trends include the integration of artificial intelligence (AI) in healthcare, the development of innovative healthcare delivery models, and increased collaboration between technology companies and healthcare providers.
Logo

Asia-Pacific Home Healthcare Market Outlook, 2028

Contact usWe are friendly and approachable, give us a call.